Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,405 | 3,770 | 96 | 23 | 0 |
| Other current assets | 40 | 41 | 0 | 0 | 0 |
| TOTAL | $2,604 | $4,032 | $96 | $23 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,604 | $4,032 | $96 | $23 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,587 | N/A | 952 | 1,199 | 0 |
| Accounts payable and accrued liabilities | 835 | 2,408 | 4,937 | 4,161 | 0 |
| Other current liabilities | N/A | N/A | 5 | 5 | 0 |
| TOTAL | $2,786 | $2,901 | $6,541 | $5,927 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,786 | $2,901 | $6,541 | $5,927 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 577 | 577 | 588 | 297 | N/A |
| Common Shares | 1 | 1 | 0 | 1 | 0 |
| Retained earnings | -17,854 | -16,082 | -13,520 | -9,481 | 0 |
| TOTAL | $-183 | $1,130 | $-6,445 | $-5,905 | $0 |
| Total Liabilities And Equity | $2,604 | $4,032 | $96 | $23 | $0 |